21 Jul FDA inspections face overhaul
The agency proposes significant revisions to oversight programs for drugs and medical products....
The agency proposes significant revisions to oversight programs for drugs and medical products....
Clinical research must be inclusive of all body types and identities....
A researcher weighs in on the current state of decentralized clinical trials, their potential to increase participant diversity, and what research is still needed to confirm their efficacy....
The COVID pandemic knocked back progress towards improving public health. Without addressing the underlying social and economic causes of ill health, it could completely stall....
More restrictive LGBTQ+ bills are being passed in the US that might negatively impact transgender individuals in clinical trials....
UW Health is recruiting volunteers for a clinical trial to test a new Alzheimer's drug recently approved by the FDA....
Feedback on the FDA's draft guidance on psychedelic research is mostly positive, but concerns arise around two-monitor recommendation....
The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease....
The FDA is expected to approve the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, some critics predict the rollout of the drug will aggravate racial disparities in elder care....
The much-anticipated draft guidance on DCTs is here, however, it might have missed several important points on delegation and data management....